Are Things Looking Up For Amarin Corp ADR (NASDAQ: AMRN)?

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Yahoo Finance discussed the stock recently as it posted Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Stocks Info

The company is listed on the NASDAQ and operates within the Drug Manufacturers – General industry segment. The current market capitalization of Amarin Corp ADR is $364.18M. A total of 1.15 million shares were traded on the day, compared to an average of 2.23M shares.

In the most recent transaction, Holt Patrick bought 14,426 shares of AMRN for 1.09 per share on Jan 22 ’24. After the transaction, the President and CEO now owns 314,426 company shares. In a previous transaction on Dec 12 ’23, Ketchum Steven B sold 34,131 shares at 0.79 per share. AMRN shares that Chief Scientific Officer owns now total 566,100.

Among the insiders who bought shares, Holt Patrick acquired of 300,000 shares on Aug 16 ’23 at a per-share price of $1.04. This resulted in the President and CEO holding 300,000 shares of AMRN after the transaction.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, AMRN has a high of $1.58 and a low of $0.65.

As of this writing, AMRN has an earnings estimate of -$0.03 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of -$0.01 per share and a lower estimate of -$0.05. The company reported an EPS of -$0.05 in the last quarter, which was -25.00% lower than expectations of -$0.04.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. AMRN’s latest balance sheet shows that the firm has $454.13M in Cash & Short Term Investments as of fiscal 2021. There were $8.58M in debt and $370.68M in liabilities at the time. Its Book Value Per Share was $1.35, while its Total Shareholder’s Equity was $667.10M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AMRN is Buy with a score of 2.60.

Most Popular

Related Posts